| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
716,216 |
525,350 |
$46.93M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
83,176 |
76,559 |
$8.34M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
214,534 |
198,735 |
$8.32M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
67,080 |
63,143 |
$7.71M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
241,726 |
222,773 |
$6.57M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,495 |
1,089 |
$6.47M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
1,277 |
1,210 |
$4.95M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,116 |
16,237 |
$4.54M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13,121 |
12,379 |
$2.18M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,729 |
17,430 |
$1.96M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,858 |
11,942 |
$1.79M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
14,713 |
8,579 |
$1.79M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
38,349 |
8,196 |
$1.75M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
3,234 |
3,120 |
$1.70M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
7,530 |
7,350 |
$1.64M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
4,242 |
4,139 |
$1.55M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24,928 |
23,562 |
$1.55M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
48,381 |
19,585 |
$1.33M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,016 |
701 |
$1.33M |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
23,873 |
23,091 |
$1.29M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63,159 |
48,746 |
$1.25M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
61,061 |
25,872 |
$1.23M |
| 90837 |
Psychotherapy, 53 minutes with patient |
16,416 |
11,211 |
$1.13M |
| 77386 |
|
4,116 |
393 |
$1.10M |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
11,605 |
7,478 |
$1.09M |
| 71046 |
Radiologic examination, chest; 2 views |
30,432 |
27,685 |
$1.09M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
82,972 |
62,718 |
$1.08M |
| 90834 |
Psychotherapy, 45 minutes with patient |
13,705 |
10,089 |
$1.02M |
| 99215 |
Prolong outpt/office vis |
17,132 |
15,118 |
$1.01M |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
602 |
570 |
$973K |
| 90832 |
Psychotherapy, 30 minutes with patient |
16,428 |
12,181 |
$948K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,990 |
2,959 |
$914K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,556 |
3,501 |
$861K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,639 |
2,566 |
$858K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,296 |
1,583 |
$836K |
| G0008 |
Administration of influenza virus vaccine |
30,736 |
29,635 |
$830K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
527 |
494 |
$827K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,458 |
6,188 |
$820K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
15,755 |
5,683 |
$806K |
| 0225U |
|
4,174 |
3,878 |
$777K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,868 |
1,819 |
$760K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,313 |
10,463 |
$759K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,373 |
8,687 |
$741K |
| 90791 |
Psychiatric diagnostic evaluation |
6,714 |
6,291 |
$705K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
20,957 |
20,258 |
$696K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,089 |
15,145 |
$637K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,110 |
15,551 |
$604K |
| J0897 |
Injection, denosumab, 1 mg |
576 |
522 |
$597K |
| 20610 |
|
5,587 |
4,893 |
$590K |
| 96130 |
|
4,730 |
4,517 |
$560K |
| 77412 |
|
5,257 |
623 |
$522K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,005 |
8,648 |
$471K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,470 |
9,252 |
$470K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,308 |
4,093 |
$430K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27,428 |
23,279 |
$402K |
| 77334 |
|
1,466 |
1,092 |
$389K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,815 |
5,651 |
$366K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,819 |
6,528 |
$364K |
| 95811 |
|
1,329 |
1,303 |
$358K |
| G0009 |
Administration of pneumococcal vaccine |
11,382 |
11,278 |
$341K |
| J0185 |
Injection, aprepitant, 1 mg |
2,538 |
1,512 |
$339K |
| 97161 |
|
8,735 |
8,454 |
$337K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
3,260 |
2,546 |
$333K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
397 |
376 |
$329K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
4,495 |
4,431 |
$327K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
4,130 |
3,967 |
$321K |
| 43235 |
|
1,090 |
1,065 |
$303K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
21,373 |
10,078 |
$303K |
| 80053 |
Comprehensive metabolic panel |
156,872 |
127,020 |
$299K |
| 52000 |
|
1,735 |
1,652 |
$280K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,814 |
7,679 |
$277K |
| 94060 |
|
3,690 |
3,561 |
$273K |
| 84443 |
Thyroid stimulating hormone (TSH) |
49,314 |
46,232 |
$271K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,076 |
1,571 |
$265K |
| 11043 |
|
2,128 |
1,637 |
$260K |
| 96367 |
|
6,589 |
3,843 |
$258K |
| 86900 |
|
6,821 |
6,124 |
$255K |
| 92557 |
|
5,263 |
5,096 |
$245K |
| 80061 |
Lipid panel |
33,746 |
32,675 |
$245K |
| J9299 |
Injection, nivolumab, 1 mg |
146 |
77 |
$244K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
6,570 |
3,811 |
$243K |
| 76830 |
Ultrasound, transvaginal |
3,157 |
3,065 |
$238K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
141 |
95 |
$235K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
4,588 |
4,398 |
$234K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
138 |
113 |
$222K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
51,340 |
44,882 |
$218K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,084 |
4,002 |
$215K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
304 |
294 |
$215K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,009 |
6,658 |
$213K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,492 |
8,237 |
$212K |
| 77336 |
|
3,871 |
1,796 |
$204K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
155,565 |
122,707 |
$204K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,393 |
6,516 |
$202K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
441 |
332 |
$202K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14,697 |
14,162 |
$192K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,295 |
2,967 |
$190K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,927 |
1,829 |
$187K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,045 |
2,973 |
$180K |
| 96131 |
|
4,223 |
4,024 |
$179K |
| 99233 |
Prolong inpt eval add15 m |
4,915 |
2,391 |
$178K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,314 |
2,209 |
$171K |
| G0010 |
Administration of hepatitis b vaccine |
5,185 |
5,144 |
$171K |
| 71250 |
|
4,536 |
4,417 |
$167K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,366 |
3,129 |
$159K |
| 77300 |
|
837 |
792 |
$159K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
136 |
126 |
$156K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
8,784 |
8,463 |
$152K |
| 93971 |
|
3,001 |
2,840 |
$148K |
| 96101 |
|
1,191 |
1,069 |
$148K |
| 10060 |
|
1,329 |
1,265 |
$145K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,025 |
12,289 |
$144K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12,950 |
12,216 |
$144K |
| 99310 |
Prolong nursin fac eval 15m |
5,751 |
4,218 |
$144K |
| 93017 |
|
3,394 |
3,285 |
$138K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
4,485 |
4,281 |
$136K |
| 64615 |
|
1,648 |
1,613 |
$136K |
| 71045 |
Radiologic examination, chest; single view |
4,215 |
3,858 |
$134K |
| 76770 |
|
2,168 |
2,128 |
$134K |
| 94726 |
|
5,083 |
4,913 |
$131K |
| 96415 |
|
3,574 |
2,517 |
$126K |
| Q3014 |
Telehealth originating site facility fee |
9,360 |
5,253 |
$123K |
| 92060 |
|
10,573 |
10,387 |
$121K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
1,610 |
1,192 |
$121K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
6,338 |
3,259 |
$119K |
| 36415 |
Collection of venous blood by venipuncture |
196,326 |
161,757 |
$119K |
| 97803 |
|
4,018 |
3,853 |
$118K |
| 92552 |
|
1,730 |
1,688 |
$116K |
| 70491 |
|
852 |
813 |
$116K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,591 |
3,496 |
$115K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,312 |
1,251 |
$115K |
| 90686 |
|
22,032 |
20,994 |
$113K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,646 |
7,174 |
$112K |
| 93798 |
|
2,226 |
355 |
$112K |
| 70496 |
|
684 |
653 |
$112K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,098 |
1,842 |
$111K |
| 47562 |
|
40 |
40 |
$109K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
320 |
311 |
$105K |
| 97162 |
|
3,394 |
3,275 |
$103K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
33,992 |
31,343 |
$103K |
| 76536 |
|
1,655 |
1,611 |
$96K |
| 92002 |
|
1,238 |
1,229 |
$95K |
| 93880 |
|
1,365 |
1,336 |
$95K |
| 96417 |
|
3,344 |
2,000 |
$94K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36,958 |
35,716 |
$94K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
43,932 |
36,141 |
$93K |
| J0178 |
Injection, aflibercept, 1 mg |
81 |
75 |
$92K |
| 72100 |
|
4,041 |
3,815 |
$92K |
| 71271 |
|
1,793 |
1,779 |
$91K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
1,462 |
1,450 |
$91K |
| 74018 |
|
4,660 |
4,079 |
$90K |
| 97597 |
|
1,862 |
1,071 |
$88K |
| 76642 |
|
1,953 |
1,883 |
$85K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,406 |
2,367 |
$83K |
| 20553 |
|
773 |
671 |
$81K |
| 90677 |
|
2,140 |
2,120 |
$80K |
| 11102 |
|
1,139 |
1,100 |
$80K |
| 73630 |
|
7,228 |
6,331 |
$80K |
| 11721 |
|
13,286 |
12,873 |
$80K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
66 |
37 |
$79K |
| 73564 |
|
3,585 |
3,126 |
$79K |
| 73030 |
|
6,720 |
5,988 |
$78K |
| 91200 |
|
1,363 |
1,348 |
$78K |
| 92588 |
|
420 |
417 |
$78K |
| 20611 |
|
623 |
565 |
$77K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
102 |
95 |
$77K |
| 93970 |
|
700 |
669 |
$77K |
| 86780 |
|
7,001 |
6,649 |
$75K |
| 17110 |
|
2,485 |
2,312 |
$75K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,240 |
1,210 |
$73K |
| 88142 |
|
6,220 |
6,107 |
$71K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
7,132 |
7,008 |
$70K |
| 20550 |
|
494 |
431 |
$69K |
| J2357 |
Injection, omalizumab, 5 mg |
47 |
25 |
$69K |
| 73610 |
|
5,565 |
4,940 |
$69K |
| 99223 |
Prolong inpt eval add15 m |
1,065 |
1,034 |
$68K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
4,026 |
3,943 |
$66K |
| 99205 |
Prolong outpt/office vis |
696 |
686 |
$66K |
| J9035 |
Injection, bevacizumab, 10 mg |
36 |
24 |
$64K |
| 76882 |
|
1,296 |
1,197 |
$63K |
| J1453 |
Injection, fosaprepitant, 1 mg |
407 |
256 |
$63K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,273 |
1,250 |
$62K |
| 95117 |
|
2,223 |
1,109 |
$61K |
| 77080 |
|
1,838 |
1,816 |
$61K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
950 |
917 |
$60K |
| 88184 |
|
476 |
428 |
$59K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
533 |
359 |
$59K |
| 87522 |
Neg quan hep c or qual rna |
2,591 |
2,467 |
$59K |
| 77066 |
Tomosynthesis, mammo |
1,084 |
1,061 |
$57K |
| 94010 |
|
4,653 |
4,522 |
$57K |
| 97165 |
|
1,474 |
1,433 |
$55K |
| 95115 |
|
2,091 |
1,120 |
$54K |
| 86003 |
|
1,727 |
1,470 |
$53K |
| 31575 |
|
709 |
681 |
$52K |
| 77301 |
|
112 |
108 |
$52K |
| 82607 |
|
9,630 |
9,244 |
$51K |
| 76801 |
|
583 |
558 |
$50K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
922 |
894 |
$50K |
| 99496 |
|
1,008 |
984 |
$50K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
1,011 |
983 |
$49K |
| 97163 |
|
974 |
955 |
$49K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25,456 |
23,197 |
$48K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,935 |
3,869 |
$48K |
| 85027 |
|
22,364 |
20,075 |
$47K |
| 64483 |
|
122 |
120 |
$47K |
| 82728 |
|
10,948 |
10,321 |
$47K |
| 73110 |
|
3,608 |
3,176 |
$47K |
| 73130 |
|
4,033 |
3,473 |
$47K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
3,154 |
2,014 |
$46K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
361 |
229 |
$45K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,130 |
19,808 |
$44K |
| 77290 |
|
352 |
288 |
$44K |
| 73562 |
|
4,464 |
3,987 |
$44K |
| 70486 |
|
1,101 |
1,050 |
$42K |
| 84702 |
|
6,922 |
5,577 |
$42K |
| 90651 |
|
4,530 |
4,486 |
$42K |
| 29581 |
|
453 |
180 |
$41K |
| 99358 |
Prolong nursin fac eval 15m |
790 |
405 |
$39K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
24,019 |
16,211 |
$39K |
| 83655 |
|
4,872 |
4,660 |
$38K |
| 87536 |
|
1,269 |
1,245 |
$38K |
| 93225 |
|
625 |
616 |
$37K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
753 |
709 |
$37K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,119 |
2,042 |
$37K |
| 96411 |
|
1,301 |
810 |
$36K |
| 98927 |
|
5,361 |
5,002 |
$36K |
| 96136 |
|
4,643 |
4,436 |
$36K |
| 36561 |
|
25 |
25 |
$36K |
| 99426 |
|
557 |
533 |
$35K |
| 73140 |
|
2,708 |
2,310 |
$35K |
| 92567 |
|
10,113 |
9,800 |
$34K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
4,337 |
4,181 |
$34K |
| 84439 |
|
11,723 |
10,881 |
$34K |
| 99454 |
|
2,270 |
2,202 |
$33K |
| 80074 |
|
2,051 |
1,976 |
$33K |
| 73502 |
|
2,961 |
2,760 |
$32K |
| 64721 |
|
40 |
38 |
$32K |
| 87510 |
|
3,183 |
3,045 |
$32K |
| 87480 |
|
3,183 |
3,045 |
$31K |
| 87660 |
|
3,183 |
3,045 |
$31K |
| 90480 |
|
1,826 |
1,789 |
$31K |
| 86480 |
|
868 |
812 |
$31K |
| H0041 |
Foster care, child, non-therapeutic, per diem |
27 |
27 |
$31K |
| 90670 |
|
8,208 |
8,154 |
$31K |
| 72040 |
|
1,891 |
1,770 |
$31K |
| 84403 |
|
2,220 |
2,084 |
$30K |
| 83970 |
|
2,700 |
2,567 |
$30K |
| 62323 |
|
134 |
125 |
$30K |
| 90732 |
|
676 |
658 |
$30K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
446 |
422 |
$30K |
| 11100 |
|
293 |
287 |
$30K |
| 97802 |
|
488 |
481 |
$29K |
| 96150 |
|
690 |
598 |
$29K |
| 93923 |
|
665 |
647 |
$28K |
| 12001 |
|
1,206 |
1,165 |
$28K |
| 83550 |
|
10,773 |
10,210 |
$28K |
| 91320 |
|
806 |
780 |
$28K |
| 73560 |
|
2,892 |
2,464 |
$28K |
| 93016 |
|
2,618 |
2,510 |
$27K |
| 77280 |
|
517 |
473 |
$27K |
| 83540 |
|
12,593 |
11,934 |
$26K |
| 83516 |
|
4,506 |
2,920 |
$26K |
| 91322 |
|
616 |
605 |
$26K |
| 72110 |
|
709 |
683 |
$26K |
| 73100 |
|
1,484 |
1,195 |
$25K |
| 97166 |
|
931 |
887 |
$25K |
| 99495 |
|
534 |
520 |
$25K |
| 82746 |
|
4,705 |
4,533 |
$24K |
| J1750 |
Injection, iron dextran, 50 mg |
197 |
177 |
$24K |
| D1206 |
Topical application of fluoride varnish |
2,029 |
2,014 |
$24K |
| 96152 |
|
674 |
515 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,244 |
2,569 |
$23K |
| 86140 |
|
18,777 |
15,670 |
$23K |
| 77065 |
Tomosynthesis, mammo |
644 |
608 |
$23K |
| 51705 |
|
480 |
396 |
$23K |
| 58301 |
|
127 |
118 |
$23K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,431 |
3,222 |
$22K |
| 97116 |
|
3,041 |
1,560 |
$22K |
| 86618 |
|
4,344 |
3,605 |
$21K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
171 |
146 |
$21K |
| 97035 |
|
4,336 |
2,056 |
$21K |
| 96910 |
|
784 |
139 |
$21K |
| 76870 |
|
550 |
523 |
$20K |
| 51702 |
|
1,398 |
1,238 |
$20K |
| 0002A |
|
599 |
590 |
$20K |
| 87186 |
|
9,997 |
9,180 |
$20K |
| 43249 |
|
31 |
28 |
$20K |
| 0001A |
|
618 |
612 |
$20K |
| 87081 |
|
9,020 |
8,735 |
$20K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,101 |
1,392 |
$20K |
| 36430 |
|
165 |
115 |
$19K |
| 99177 |
|
2,571 |
2,510 |
$19K |
| 96158 |
|
989 |
615 |
$19K |
| 78264 |
|
102 |
101 |
$19K |
| 58300 |
|
460 |
432 |
$18K |
| 82105 |
|
2,394 |
2,275 |
$18K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
2,669 |
2,588 |
$18K |
| 87340 |
|
5,423 |
5,187 |
$18K |
| 11056 |
|
729 |
697 |
$18K |
| 90746 |
|
310 |
300 |
$18K |
| 83735 |
|
32,683 |
23,687 |
$17K |
| 99221 |
|
433 |
393 |
$17K |
| 90961 |
|
462 |
436 |
$17K |
| 96127 |
|
3,496 |
3,360 |
$17K |
| 95816 |
|
631 |
594 |
$17K |
| 86762 |
|
3,419 |
3,298 |
$16K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,491 |
1,454 |
$16K |
| 70498 |
|
667 |
643 |
$16K |
| 11046 |
|
144 |
105 |
$16K |
| 73080 |
|
1,438 |
1,282 |
$16K |
| 82784 |
|
4,369 |
3,836 |
$16K |
| 93308 |
|
125 |
125 |
$16K |
| 94762 |
|
318 |
317 |
$16K |
| 96137 |
|
3,301 |
3,126 |
$16K |
| 93922 |
|
791 |
783 |
$16K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
848 |
838 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
889 |
767 |
$15K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,592 |
821 |
$15K |
| 83880 |
|
6,341 |
5,648 |
$15K |
| 77338 |
|
118 |
114 |
$15K |
| 72050 |
|
420 |
411 |
$15K |
| 90661 |
|
864 |
858 |
$15K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
74 |
57 |
$14K |
| 73590 |
|
1,426 |
1,250 |
$14K |
| 0064A |
|
1,020 |
930 |
$14K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
357 |
351 |
$14K |
| 80076 |
|
4,188 |
3,960 |
$14K |
| 99188 |
|
1,080 |
1,078 |
$13K |
| 86706 |
|
2,953 |
2,805 |
$13K |
| 98928 |
|
3,375 |
3,141 |
$13K |
| 82570 |
|
9,177 |
8,562 |
$13K |
| 86038 |
|
2,556 |
2,421 |
$13K |
| 85610 |
|
35,171 |
24,633 |
$13K |
| 99406 |
|
868 |
830 |
$12K |
| 90716 |
|
2,672 |
2,662 |
$12K |
| 81001 |
|
38,805 |
34,412 |
$12K |
| 74178 |
|
72 |
66 |
$12K |
| 87427 |
|
2,162 |
1,051 |
$12K |
| 97167 |
|
361 |
355 |
$12K |
| 92015 |
Determination of refractive state |
6,702 |
6,570 |
$12K |
| 74174 |
|
79 |
78 |
$11K |
| 90870 |
|
52 |
24 |
$11K |
| 11055 |
|
572 |
554 |
$11K |
| 77295 |
|
27 |
24 |
$11K |
| 0124A |
|
852 |
846 |
$11K |
| 88342 |
|
4,721 |
4,498 |
$11K |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
427 |
321 |
$11K |
| 73090 |
|
879 |
732 |
$11K |
| 92523 |
|
84 |
84 |
$11K |
| 86666 |
|
3,053 |
1,487 |
$11K |
| 17000 |
|
1,725 |
1,636 |
$11K |
| 87905 |
|
4,118 |
3,930 |
$11K |
| 98926 |
|
2,742 |
2,543 |
$10K |
| 0004A |
|
574 |
561 |
$10K |
| 85652 |
|
12,224 |
10,364 |
$10K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
155 |
154 |
$10K |
| 82785 |
|
1,687 |
1,500 |
$10K |
| 87077 |
|
9,269 |
8,445 |
$10K |
| 80164 |
|
2,646 |
2,340 |
$10K |
| 72070 |
|
461 |
445 |
$10K |
| 93793 |
|
4,009 |
2,039 |
$10K |
| 84146 |
|
993 |
959 |
$10K |
| 87808 |
|
3,928 |
3,750 |
$10K |
| 82043 |
|
6,871 |
6,640 |
$9K |
| 81025 |
|
20,100 |
18,452 |
$9K |
| 83690 |
|
19,574 |
17,460 |
$9K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
27 |
26 |
$9K |
| 83993 |
|
682 |
661 |
$9K |
| 0003A |
|
326 |
324 |
$9K |
| 80178 |
|
3,306 |
2,903 |
$9K |
| 90620 |
|
499 |
495 |
$8K |
| 64493 |
|
31 |
25 |
$8K |
| 86704 |
|
2,052 |
1,945 |
$8K |
| 90662 |
|
2,623 |
2,573 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
80 |
76 |
$8K |
| C9447 |
Injection, phenylephrine and ketorolac, 4 ml vial |
143 |
111 |
$8K |
| 80159 |
|
1,576 |
1,317 |
$8K |
| 94729 |
|
5,070 |
4,900 |
$8K |
| 52310 |
|
12 |
12 |
$8K |
| 86850 |
|
7,108 |
6,394 |
$7K |
| 84425 |
|
704 |
682 |
$7K |
| 83001 |
|
844 |
809 |
$7K |
| 87070 |
|
5,222 |
4,698 |
$7K |
| 73501 |
|
963 |
875 |
$7K |
| 82947 |
|
2,245 |
2,183 |
$7K |
| 96112 |
|
49 |
48 |
$7K |
| 96156 |
|
201 |
188 |
$7K |
| 99427 |
|
174 |
166 |
$7K |
| 69209 |
|
2,832 |
2,727 |
$7K |
| 86803 |
|
1,294 |
1,241 |
$7K |
| 99359 |
Prolong nursin fac eval 15m |
220 |
106 |
$7K |
| 87147 |
|
3,110 |
2,635 |
$7K |
| 72170 |
|
497 |
463 |
$7K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
395 |
291 |
$7K |
| 92134 |
|
1,898 |
1,839 |
$6K |
| 0081A |
|
156 |
153 |
$6K |
| 86200 |
|
1,324 |
1,237 |
$6K |
| 90619 |
|
1,060 |
1,044 |
$6K |
| 87205 |
|
8,482 |
7,724 |
$6K |
| 84153 |
|
1,722 |
1,614 |
$6K |
| 11730 |
|
82 |
78 |
$6K |
| 96161 |
|
209 |
209 |
$6K |
| 0011A |
|
217 |
216 |
$6K |
| 96523 |
|
324 |
305 |
$5K |
| 73700 |
|
89 |
82 |
$5K |
| 84100 |
|
7,175 |
5,827 |
$5K |
| 93242 |
|
226 |
225 |
$5K |
| 86753 |
|
1,597 |
1,478 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
190 |
189 |
$5K |
| 90734 |
|
3,446 |
3,423 |
$5K |
| 69210 |
|
927 |
899 |
$5K |
| 36593 |
|
52 |
41 |
$5K |
| 87045 |
|
1,144 |
1,101 |
$5K |
| 86255 |
|
803 |
722 |
$5K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
357 |
338 |
$5K |
| 74160 |
|
39 |
38 |
$5K |
| 82950 |
|
1,124 |
1,104 |
$5K |
| 86430 |
|
2,113 |
1,984 |
$5K |
| 0012A |
|
196 |
195 |
$5K |
| 64450 |
|
25 |
24 |
$5K |
| 86617 |
|
752 |
654 |
$5K |
| 99173 |
|
2,327 |
2,294 |
$5K |
| 88307 |
|
1,032 |
818 |
$4K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
2,485 |
482 |
$4K |
| 91010 |
|
25 |
25 |
$4K |
| 0134A |
|
370 |
366 |
$4K |
| 11981 |
|
79 |
77 |
$4K |
| 84165 |
|
1,940 |
1,793 |
$4K |
| 74230 |
|
89 |
85 |
$4K |
| 90688 |
|
433 |
427 |
$4K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
13 |
12 |
$4K |
| 87902 |
|
66 |
63 |
$4K |
| 11750 |
|
20 |
12 |
$4K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
26 |
25 |
$4K |
| 98929 |
|
1,024 |
978 |
$4K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
52 |
37 |
$4K |
| 86787 |
|
690 |
673 |
$4K |
| 85018 |
|
5,271 |
4,830 |
$4K |
| 96402 |
|
664 |
609 |
$4K |
| 82533 |
|
2,405 |
2,056 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
5,910 |
5,278 |
$4K |
| 82550 |
|
4,966 |
4,211 |
$3K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
70 |
38 |
$3K |
| 84481 |
|
412 |
394 |
$3K |
| 83615 |
|
8,382 |
6,449 |
$3K |
| 0082A |
|
79 |
79 |
$3K |
| 0154A |
|
147 |
147 |
$3K |
| 73522 |
|
146 |
140 |
$3K |
| 82565 |
|
4,108 |
3,743 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,206 |
6,439 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
148 |
103 |
$3K |
| 86360 |
|
428 |
415 |
$3K |
| 82248 |
|
1,176 |
1,019 |
$3K |
| 81514 |
|
1,960 |
1,903 |
$3K |
| 84156 |
|
2,239 |
1,880 |
$3K |
| 73620 |
|
533 |
497 |
$3K |
| 86481 |
|
84 |
82 |
$3K |
| 82024 |
|
2,068 |
1,743 |
$3K |
| 99460 |
|
49 |
49 |
$3K |
| 84402 |
|
244 |
229 |
$3K |
| 99442 |
|
582 |
558 |
$3K |
| 88108 |
|
706 |
663 |
$3K |
| 84550 |
|
2,216 |
1,988 |
$3K |
| 86160 |
|
292 |
260 |
$3K |
| 93976 |
|
38 |
37 |
$3K |
| 87329 |
|
413 |
397 |
$3K |
| 86359 |
|
456 |
440 |
$3K |
| 78306 |
|
26 |
25 |
$3K |
| 82670 |
|
169 |
163 |
$3K |
| 85730 |
|
3,885 |
3,475 |
$3K |
| 96160 |
|
81 |
81 |
$3K |
| 77470 |
|
13 |
12 |
$2K |
| 81003 |
|
23,898 |
21,910 |
$2K |
| 96113 |
|
49 |
48 |
$2K |
| 85379 |
|
4,748 |
4,463 |
$2K |
| 73600 |
|
200 |
176 |
$2K |
| 64400 |
|
15 |
12 |
$2K |
| 86696 |
|
183 |
175 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
34 |
25 |
$2K |
| 87328 |
|
317 |
304 |
$2K |
| 96116 |
|
27 |
27 |
$2K |
| 80305 |
|
2,245 |
1,218 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23,289 |
21,775 |
$2K |
| 82378 |
|
1,916 |
1,565 |
$2K |
| 85014 |
|
2,368 |
1,990 |
$2K |
| 99350 |
Prolong home eval add 15m |
99 |
79 |
$2K |
| 86708 |
|
438 |
411 |
$2K |
| 99462 |
|
74 |
64 |
$2K |
| 29125 |
|
612 |
579 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
25,210 |
23,115 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,829 |
16,128 |
$2K |
| 86580 |
|
193 |
169 |
$2K |
| 96121 |
|
25 |
25 |
$2K |
| 92555 |
|
1,246 |
1,220 |
$2K |
| 96132 |
|
12 |
12 |
$2K |
| 74220 |
|
26 |
26 |
$2K |
| 73000 |
|
85 |
66 |
$2K |
| 86694 |
|
155 |
134 |
$2K |
| 82140 |
|
678 |
583 |
$2K |
| 11982 |
|
13 |
12 |
$2K |
| 82103 |
|
457 |
421 |
$2K |
| 0031A |
|
65 |
65 |
$2K |
| 12002 |
|
204 |
197 |
$2K |
| 17250 |
|
18 |
15 |
$1K |
| 84484 |
|
19,287 |
13,386 |
$1K |
| 86695 |
|
183 |
175 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
26,986 |
23,957 |
$1K |
| 88304 |
|
1,808 |
1,565 |
$1K |
| 73070 |
|
105 |
93 |
$1K |
| 95909 |
|
14 |
14 |
$1K |
| 87040 |
|
4,871 |
2,752 |
$1K |
| 84460 |
|
534 |
509 |
$1K |
| 87449 |
|
368 |
351 |
$1K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
70 |
25 |
$1K |
| 70355 |
|
45 |
38 |
$1K |
| 87075 |
|
765 |
681 |
$1K |
| 29515 |
|
17 |
16 |
$1K |
| 86364 |
|
207 |
191 |
$1K |
| 0073A |
|
30 |
30 |
$1K |
| 81511 |
|
12 |
12 |
$1K |
| 11104 |
|
17 |
15 |
$1K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
109 |
105 |
$1K |
| 72114 |
|
26 |
26 |
$1K |
| 12011 |
|
84 |
80 |
$1K |
| 87324 |
|
330 |
315 |
$1K |
| 80175 |
|
238 |
222 |
$1K |
| 0071A |
|
28 |
28 |
$1K |
| 95806 |
|
26 |
24 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
26,747 |
19,471 |
$1K |
| 64405 |
|
14 |
14 |
$1K |
| 99306 |
Prolong nursin fac eval 15m |
39 |
39 |
$1K |
| 77399 |
|
14 |
14 |
$1K |
| 92551 |
|
157 |
157 |
$1K |
| 83002 |
|
95 |
90 |
$1K |
| 87478 |
|
119 |
117 |
$999.89 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
20,294 |
17,650 |
$987.20 |
| 86376 |
|
108 |
101 |
$977.48 |
| 86235 |
|
62 |
37 |
$964.20 |
| 73660 |
|
106 |
104 |
$922.29 |
| 83520 |
|
149 |
139 |
$920.94 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
17 |
$910.00 |
| 82150 |
|
1,042 |
935 |
$902.81 |
| 0083A |
|
21 |
21 |
$891.24 |
| 87102 |
|
569 |
500 |
$890.92 |
| 99443 |
|
86 |
81 |
$888.23 |
| 83883 |
|
652 |
558 |
$885.37 |
| 87400 |
|
3,021 |
1,785 |
$876.34 |
| 0173A |
|
36 |
36 |
$865.45 |
| 51798 |
|
2,086 |
1,879 |
$822.13 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18,616 |
16,115 |
$817.24 |
| 86765 |
|
97 |
91 |
$802.01 |
| 90653 |
|
273 |
272 |
$794.86 |
| 73120 |
|
44 |
39 |
$784.37 |
| 82247 |
|
233 |
141 |
$768.66 |
| 97810 |
|
69 |
61 |
$767.08 |
| 99336 |
|
26 |
26 |
$764.41 |
| 74022 |
|
101 |
96 |
$748.61 |
| 87484 |
|
119 |
117 |
$722.70 |
| 87469 |
|
119 |
117 |
$722.39 |
| 87468 |
|
119 |
117 |
$722.39 |
| 85045 |
|
678 |
606 |
$720.65 |
| 86308 |
|
1,303 |
1,250 |
$714.91 |
| 98925 |
|
248 |
228 |
$693.13 |
| 86705 |
|
72 |
72 |
$659.12 |
| 87430 |
|
2,167 |
2,091 |
$658.56 |
| 64447 |
|
80 |
75 |
$651.38 |
| 86735 |
|
81 |
76 |
$633.93 |
| 90744 |
|
4,571 |
4,555 |
$626.74 |
| 96377 |
|
142 |
95 |
$606.76 |
| 96159 |
|
115 |
89 |
$583.59 |
| 70030 |
|
16 |
13 |
$579.17 |
| 82542 |
|
154 |
139 |
$559.84 |
| 80197 |
|
187 |
89 |
$548.01 |
| 93243 |
|
13 |
13 |
$545.27 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
26,573 |
21,470 |
$541.58 |
| 0034A |
|
32 |
32 |
$527.02 |
| 95886 |
|
210 |
204 |
$489.59 |
| 92133 |
|
438 |
415 |
$477.23 |
| 74019 |
|
43 |
42 |
$473.13 |
| 51784 |
|
15 |
12 |
$470.11 |
| 80156 |
|
113 |
105 |
$444.26 |
| 86225 |
|
104 |
98 |
$443.12 |
| 86682 |
|
44 |
44 |
$429.14 |
| J3490 |
Unclassified drugs |
1,034 |
494 |
$424.60 |
| 90656 |
|
959 |
958 |
$418.00 |
| 93270 |
|
25 |
24 |
$417.02 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,757 |
3,639 |
$412.76 |
| 86920 |
|
266 |
181 |
$372.19 |
| 83605 |
|
5,103 |
4,351 |
$370.56 |
| A4649 |
Surgical supply; miscellaneous |
509 |
378 |
$364.94 |
| 87015 |
|
144 |
142 |
$357.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14,865 |
13,670 |
$352.00 |
| 84132 |
|
475 |
315 |
$346.85 |
| 99334 |
|
24 |
22 |
$344.34 |
| 88187 |
|
17 |
12 |
$339.30 |
| 82010 |
|
858 |
756 |
$324.85 |
| 90680 |
|
5,925 |
5,903 |
$316.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18,221 |
14,553 |
$313.28 |
| 99441 |
|
96 |
93 |
$310.63 |
| 11719 |
|
88 |
84 |
$306.80 |
| 94761 |
|
516 |
481 |
$305.04 |
| 81002 |
|
1,389 |
1,345 |
$303.58 |
| 82671 |
|
14 |
12 |
$290.70 |
| 86709 |
|
67 |
63 |
$285.53 |
| 82962 |
|
6,789 |
4,467 |
$283.27 |
| 92250 |
|
127 |
123 |
$278.22 |
| 86769 |
|
12 |
12 |
$274.42 |
| 86800 |
|
39 |
37 |
$271.72 |
| 82390 |
|
92 |
87 |
$263.93 |
| 82310 |
|
197 |
169 |
$256.11 |
| 80050 |
General health panel |
15 |
15 |
$245.00 |
| 94664 |
|
1,719 |
1,331 |
$243.99 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,152 |
3,477 |
$235.45 |
| 83021 |
|
83 |
83 |
$234.78 |
| 72220 |
|
49 |
44 |
$234.09 |
| 92083 |
|
57 |
56 |
$231.35 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
164 |
83 |
$223.94 |
| 87338 |
|
29 |
28 |
$223.79 |
| 0013A |
|
13 |
13 |
$223.50 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
313 |
268 |
$213.75 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
12 |
$200.70 |
| 87420 |
|
250 |
237 |
$199.07 |
| 71101 |
|
16 |
16 |
$191.42 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,440 |
1,330 |
$185.88 |
| 83020 |
|
84 |
83 |
$180.18 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,308 |
6,140 |
$179.89 |
| 80069 |
|
54 |
52 |
$178.95 |
| 36600 |
|
31 |
25 |
$175.26 |
| 90715 |
|
10,221 |
9,819 |
$173.66 |
| 84480 |
|
29 |
27 |
$155.98 |
| 84450 |
|
68 |
63 |
$154.76 |
| 82803 |
|
951 |
832 |
$148.83 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
3,209 |
3,094 |
$147.76 |
| 86677 |
|
16 |
16 |
$147.30 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
7,397 |
5,190 |
$146.86 |
| 73060 |
|
15 |
14 |
$146.74 |
| 82951 |
|
12 |
12 |
$141.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,570 |
2,798 |
$140.36 |
| 92556 |
|
213 |
203 |
$129.12 |
| J3480 |
Injection, potassium chloride, per 2 meq |
956 |
711 |
$125.75 |
| 94375 |
|
13 |
13 |
$124.65 |
| 99348 |
|
19 |
17 |
$120.65 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
9,393 |
8,721 |
$116.57 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,267 |
6,532 |
$115.12 |
| 82985 |
|
26 |
25 |
$103.75 |
| 93226 |
|
498 |
490 |
$102.27 |
| C1769 |
Guide wire |
3,038 |
2,788 |
$102.26 |
| 82977 |
|
24 |
24 |
$94.79 |
| 36416 |
|
34,579 |
28,714 |
$92.44 |
| 83721 |
|
25 |
24 |
$84.43 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,221 |
1,943 |
$82.47 |
| 89051 |
|
527 |
305 |
$78.49 |
| 98968 |
|
22 |
12 |
$76.68 |
| 86901 |
|
6,821 |
6,124 |
$75.89 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
2,515 |
2,410 |
$72.39 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,507 |
2,217 |
$63.56 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
1,417 |
1,338 |
$63.56 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
7,942 |
7,306 |
$60.29 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
16,301 |
7,087 |
$58.22 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,863 |
1,815 |
$57.32 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,314 |
1,283 |
$57.32 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,192 |
2,938 |
$57.23 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
2,266 |
2,158 |
$52.96 |
| 96376 |
|
3,379 |
2,999 |
$52.00 |
| 17003 |
|
241 |
218 |
$49.90 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
19,630 |
19,187 |
$41.04 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,177 |
1,528 |
$40.63 |
| 92136 |
|
27 |
24 |
$37.36 |
| 84075 |
|
29 |
25 |
$37.33 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
362 |
357 |
$35.09 |
| 82952 |
|
12 |
12 |
$32.34 |
| V2632 |
Posterior chamber intraocular lens |
542 |
407 |
$28.13 |
| G0143 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision |
700 |
688 |
$27.85 |
| 83010 |
|
15 |
13 |
$25.16 |
| J9045 |
Injection, carboplatin, 50 mg |
839 |
483 |
$24.43 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
5,276 |
2,530 |
$24.43 |
| 80177 |
|
12 |
12 |
$24.32 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
26 |
25 |
$24.00 |
| 84520 |
|
14 |
12 |
$23.86 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,236 |
2,743 |
$23.25 |
| 73552 |
|
14 |
13 |
$22.63 |
| 94760 |
|
1,883 |
1,325 |
$22.00 |
| 86301 |
|
16 |
14 |
$20.81 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
715 |
659 |
$16.67 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,456 |
1,151 |
$13.76 |
| 82040 |
|
25 |
24 |
$13.76 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,777 |
1,681 |
$12.68 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,993 |
1,301 |
$11.78 |
| 96368 |
|
2,043 |
1,194 |
$11.78 |
| 88173 |
|
587 |
410 |
$9.96 |
| 85384 |
|
12 |
12 |
$8.68 |
| 82800 |
|
61 |
53 |
$8.66 |
| 82553 |
|
30 |
28 |
$7.92 |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,796 |
3,777 |
$7.46 |
| 90474 |
|
5,877 |
5,858 |
$5.94 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,214 |
1,027 |
$5.25 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,602 |
2,407 |
$1.47 |
| J1836 |
Injection, metronidazole, 10 mg |
27 |
24 |
$0.21 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
24,361 |
13,181 |
$0.00 |
| C1776 |
Joint device (implantable) |
440 |
404 |
$0.00 |
| 90633 |
|
5,499 |
5,473 |
$0.00 |
| 99051 |
|
1,788 |
1,745 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,016 |
846 |
$0.00 |
| 90707 |
|
2,638 |
2,626 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
343 |
328 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
2,111 |
1,899 |
$0.00 |
| 90710 |
|
2,638 |
2,626 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,175 |
3,124 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
770 |
291 |
$0.00 |
| 91300 |
|
1,058 |
983 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
280 |
274 |
$0.00 |
| 87999 |
|
44 |
41 |
$0.00 |
| 90713 |
|
245 |
244 |
$0.00 |
| 93321 |
|
314 |
310 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,342 |
2,062 |
$0.00 |
| 90700 |
|
310 |
308 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
873 |
847 |
$0.00 |
| 99152 |
|
2,648 |
2,507 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
691 |
387 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
582 |
568 |
$0.00 |
| 90685 |
|
3,127 |
3,113 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,137 |
867 |
$0.00 |
| 76942 |
|
485 |
472 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,111 |
1,020 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
150 |
67 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
271 |
245 |
$0.00 |
| 84145 |
|
39 |
38 |
$0.00 |
| 76937 |
|
1,154 |
1,080 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
26 |
24 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
721 |
659 |
$0.00 |
| 88313 |
|
225 |
129 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
116 |
90 |
$0.00 |
| 77387 |
|
154 |
24 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
440 |
397 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
15 |
13 |
$0.00 |
| 91321 |
|
309 |
309 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
383 |
363 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
699 |
672 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
218 |
214 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
24 |
24 |
$0.00 |
| 80143 |
|
56 |
50 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
13 |
12 |
$0.00 |
| 88104 |
|
13 |
12 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
286 |
166 |
$0.00 |
| 90648 |
|
36 |
36 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
130 |
108 |
$0.00 |
| A6021 |
Collagen dressing, sterile, size 16 sq. in. or less, each |
32 |
24 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
78 |
50 |
$0.00 |
| 90671 |
|
44 |
44 |
$0.00 |
| 90380 |
|
30 |
30 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
34 |
13 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
123 |
117 |
$0.00 |
| C1758 |
Catheter, ureteral |
44 |
40 |
$0.00 |
| 90649 |
|
13 |
13 |
$0.00 |
| 80179 |
|
51 |
46 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
58 |
58 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
12 |
12 |
$0.00 |
| 96133 |
|
12 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
27 |
27 |
$0.00 |
| A9270 |
Non-covered item or service |
1,327 |
1,127 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
1,963 |
1,855 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,948 |
1,749 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
120 |
116 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
522 |
281 |
$0.00 |
| 90696 |
|
2,262 |
2,250 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
832 |
662 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
267 |
177 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,922 |
1,799 |
$0.00 |
| 90697 |
|
292 |
291 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
220 |
217 |
$0.00 |
| 91306 |
|
280 |
235 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
3,339 |
2,651 |
$0.00 |
| C1781 |
Mesh (implantable) |
58 |
51 |
$0.00 |
| 90698 |
|
8,190 |
8,162 |
$0.00 |
| 36000 |
|
135 |
122 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
37 |
36 |
$0.00 |
| G8986 |
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting |
54 |
53 |
$0.00 |
| 88172 |
|
87 |
79 |
$0.00 |
| 90636 |
|
27 |
25 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
648 |
607 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
52 |
38 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
241 |
185 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
143 |
139 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
661 |
619 |
$0.00 |
| 88185 |
|
295 |
177 |
$0.00 |
| 90632 |
|
213 |
209 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
94 |
81 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
100 |
98 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
498 |
481 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
675 |
614 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
68 |
65 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
404 |
309 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
168 |
163 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
761 |
673 |
$0.00 |
| 88300 |
|
13 |
13 |
$0.00 |
| 64494 |
|
16 |
12 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
42 |
24 |
$0.00 |
| 77417 |
|
69 |
39 |
$0.00 |
| 91301 |
|
305 |
297 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
16 |
14 |
$0.00 |
| 74420 |
|
63 |
61 |
$0.00 |
| A4364 |
Adhesive, liquid or equal, any type, per oz |
110 |
108 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
207 |
78 |
$0.00 |
| 88341 |
|
317 |
255 |
$0.00 |
| 77001 |
|
74 |
71 |
$0.00 |
| 88311 |
|
45 |
36 |
$0.00 |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
26 |
26 |
$0.00 |
| 91303 |
|
46 |
46 |
$0.00 |
| 29130 |
|
13 |
13 |
$0.00 |
| 90381 |
|
84 |
84 |
$0.00 |
| 64415 |
|
16 |
16 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
14 |
13 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
33 |
26 |
$0.00 |